Results 1 to 10 of about 801,641 (157)

Sigma-1 receptor and seizures

open access: yesPharmacological Research, 2023
Over the last decade, sigma-1 receptor (Sig1R) has been recognized as a valid target for the treatment of seizure disorders and seizure-related comorbidities.
Edijs Vavers   +2 more
doaj   +4 more sources

Pharmacological and Pathological Implications of Sigma-1 Receptor in Neurodegenerative Diseases [PDF]

open access: yesBiomedicines
Originally identified as a potential receptor for opioids, the sigma-1 receptor is now recognized as an intracellular chaperone protein associated with mitochondria-associated membranes at the endoplasmic reticulum (ER).
Noah Drewes   +3 more
doaj   +2 more sources

Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication

open access: yesJournal of Pharmacological Sciences, 2015
Endoplasmic reticulum (ER) protein sigma-1 receptor represents unique chaperone activity in the central nervous system, and it exerts a potent influence on a number of neurotransmitter systems. Several lines of evidence suggest that activation of sigma-1
Kenji Hashimoto
doaj   +3 more sources

Sigma-2 Receptor—A Potential Target for Cancer/Alzheimer’s Disease Treatment via Its Regulation of Cholesterol Homeostasis

open access: yesMolecules, 2020
The sigma receptors were classified into sigma-1 and sigma-2 receptor based on their different pharmacological profiles. In the past two decades, our understanding of the biological and pharmacological properties of the sigma-1 receptor is increasing ...
Kai Yang   +5 more
doaj   +3 more sources

Sigma-1 receptor: The novel intracellular target of neuropsychotherapeutic drugs

open access: yesJournal of Pharmacological Sciences, 2015
Sigma-1 receptor ligands have been long expected to serve as drugs for treatment of human diseases such as neurodegenerative disorders, depression, idiopathic pain, drug abuse, and cancer.
Teruo Hayashi
doaj   +3 more sources

Allosteric Modulators of Sigma-1 Receptor: A Review [PDF]

open access: yesFrontiers in Pharmacology, 2019
Allosteric modulators of sigma-1 receptor (Sig1R) are described as compounds that can increase the activity of some Sig1R ligands that compete with (+)-pentazocine, one of the classic prototypical ligands that binds to the orthosteric Sig1R binding site.
Edijs Vavers   +3 more
doaj   +3 more sources

The Sigma-1 Receptor in Cellular Stress Signaling [PDF]

open access: yesFrontiers in Neuroscience, 2019
After decades of research, the sigma-1 receptor (Sig-1R)’s structure, and molecular functions are being unveiled. Sig-1R is an integral endoplasmic reticulum (ER) membrane protein which forms an oligomer and binds a variety of psychotropic drugs.
Teruo Hayashi
doaj   +3 more sources

The sigma-1 receptor as a neurohomeostatic decision hub for GABARAP-mediated receptor trafficking and macroautophagy [PDF]

open access: yesFrontiers in Molecular Biosciences
Gamma-aminobutyric acid receptor-associated protein (GABARAP) is a multifunctional member of the autophagy-related (ATG8) protein family, playing key roles in two distinct cellular pathways: macroautophagy and plasma membrane protein trafficking.
Marius Wilhelm Baeken   +4 more
doaj   +2 more sources

Sigma-1 Receptors in Depression: Mechanism and Therapeutic Development

open access: yesFrontiers in Pharmacology, 2022
Depression is the most common type of neuropsychiatric illness and has increasingly become a major cause of disability. Unfortunately, the recent global pandemic of COVID-19 has dramatically increased the incidence of depression and has significantly ...
Peng Ren   +7 more
doaj   +3 more sources

Viewpoints Sigma-1 receptor agonist fluvoxamine for multiple sclerosis [PDF]

open access: yesBrain, Behavior, & Immunity - Health
Accumulating evidence suggests that the Epstein-Barr virus (EBV) plays a key role in the development of multiple sclerosis (MS). Additionally, depressive symptoms often precede the onset of MS.
Kenji Hashimoto
doaj   +2 more sources

Home - About - Disclaimer - Privacy